InterVenn Biosciences Welcomes Accomplished Diagnostics Executive Joshua Stahl as CEO
Stahl will leverage proven experience in building innovative diagnostic organizations to accelerate InterVenn’s commercialization efforts
Anzu Partners Closes Third Venture Fund Focused on Companies Enabling Next-Gen Solutions in Clean Tech, Industrial, and Life Sciences Technologies
Fund III cohort accelerates the energy transition, facilitates discovery of better therapeutics and advances critical industries.
Aspinity Raises $5 Million Series B Funding to Bring Breakthrough AI/ML Technology to a Global Market
Strategic partnership with Unitrontech accelerates time to market for AI-based automotive impact and other AIoT solutions
Nanocellect Biomedical Welcomes Peter Vander Horn as Senior VP of Research & Development
Dr. Vander Horn’s expertise will further advance NanoCellect’s ability to deliver innovative solutions to the cellular research markets
BioSkryb Genomics Joins NIST Genome Editing Consortium to Define Standards in Genome Editing Research and Commercialization
As a part of the NIST Genome Editing Consortium, BioSkryb will help enable increased confidence in gene edited research and commercial products.
NTx Awarded BARDA DRIVe Vaccines on Demand Contract to Demonstrate a Novel RNA Vaccine Production Platform
NTx will collaborate with Houston Methodist Hospital to demonstrate how NTxscribe® can fulfill the need for a rapidly deployable RNA vaccine manufacturing capability
Xendee Supports Futuristic Project ‘NEOM’ Enabling Conversion to Renewable Energy
Xendee is proud to announce a contract supporting NEOM, the visionary project aiming to create a sustainable city in the Kingdom of Saudi Arabia.
6K Additive Partners with Agile Space Industries to Advance Mission to the Moon
6K Additive’s Nickel 625 powder is being qualified for use in Agile’s A2200 engine due to being part of a mission to the moon.
6K Energy to Implement Forge Nano Equipment for Commercial Production of NMC 811
6K Energy adopts Atomic Armor technology, aka Commercial-scale Atomic Layer Deposition (ALD) equipment, for the production of US-made high-performance low-cost NMC cathodes.
BioFlyte Launches First-of-Its-Kind Biothreat Surveillance Pilot Program at Pittsburgh International Airport
In partnership with PIT’s xBridge innovation center, BioFlyte’s bioaerosol threat detection technology will screen the airport air for toxins that could be used to attack critical infrastructure.